Patents by Inventor Xiaofen Ye

Xiaofen Ye has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210338684
    Abstract: The present invention provides diagnostic and therapeutic methods for cancer. The invention provides methods of determining whether a patient having a cancer is likely to respond to treatment comprising an inhibitor of H3K27 methylation, methods of predicting responsiveness of a patient having a cancer to treatment comprising one or more inhibitors of H3K27 methylation, methods of selecting a therapy for a patient having a cancer, and methods of treating cancer based on expression levels of biomarkers of the invention (e.g., the expression level of SMARCA2 or the occupancy level of H3K27 at a SMARCA2 promoter).
    Type: Application
    Filed: July 8, 2021
    Publication date: November 4, 2021
    Inventors: Robert L. YAUCH, Xiaofen YE, Thomas E. JANUARIO
  • Publication number: 20200129519
    Abstract: The present invention provides diagnostic and therapeutic methods for cancer. The invention provides methods of determining whether a patient having a cancer is likely to respond to treatment comprising an inhibitor of H3K27 methylation, methods of predicting responsiveness of a patient having a cancer to treatment comprising one or more inhibitors of H3K27 methylation, methods of selecting a therapy for a patient having a cancer, and methods of treating cancer based on expression levels of biomarkers of the invention (e.g., the expression level of SIV1ARCA2 or the occupancy level of H3K27 at a SMARCA2 promoter).
    Type: Application
    Filed: June 8, 2017
    Publication date: April 30, 2020
    Applicants: Genentech, Inc., Genentech, Inc.
    Inventors: Robert L. YAUCH, Xiaofen YE, Thomas E. JANUARIO
  • Patent number: 9925240
    Abstract: Provided herein are combination therapies for the treatment of pathological conditions, such as cancer, using an antagonist of FGFR signaling.
    Type: Grant
    Filed: March 6, 2014
    Date of Patent: March 27, 2018
    Assignee: GENENTECH, INC.
    Inventors: Robert L. Yauch, Xiaofen Ye, Avi Ashkenazi
  • Publication number: 20160250287
    Abstract: Provided herein are combination therapies for the treatment of pathological conditions, such as cancer, using an antagonist of FGFR signaling.
    Type: Application
    Filed: March 6, 2014
    Publication date: September 1, 2016
    Applicant: Genentech, Inc.
    Inventors: Robert L. YAUCH, Xiaofen YE, Avi ASHKENAZI
  • Patent number: 8853369
    Abstract: The invention provides anti-Axl antibodies and methods of using the same.
    Type: Grant
    Filed: December 7, 2012
    Date of Patent: October 7, 2014
    Assignee: Genentech, Inc.
    Inventors: Lin Pei, Yan Wu, Xiaofen Ye
  • Publication number: 20130243753
    Abstract: The invention provides anti-Axl antibodies and methods of using the same.
    Type: Application
    Filed: December 7, 2012
    Publication date: September 19, 2013
    Applicant: GENENTECH, INC.
    Inventors: Lin Pei, Yan Wu, Xiaofen Ye
  • Patent number: RE47761
    Abstract: The invention provides anti-Axl antibodies and methods of using the same.
    Type: Grant
    Filed: October 6, 2016
    Date of Patent: December 10, 2019
    Assignee: Genentech, Inc.
    Inventors: Lin Pei, Yan Wu, Xiaofen Ye